Skip to main content
. 2014 Nov 6;86(8):905–910. doi: 10.1136/jnnp-2014-307897

Table 4.

Potential risk factors for PD at baseline and 6 months after SAH

Clinical characteristics Baseline 6 months’ follow-up
With PD
N=37
Without PD
N=47
With PD
N=22
Without PD
N=62
Age; mean (SD) 57.5 (11.9) 54.3 (11.8) 52.9 (12.0) 56.7 (11.8)
Male 10 (27%) 18 (38%) 10 (45%) 18 (29%)
Days in hospital; mean (SD) 18.4 (8.1) 18.0 (10.9) 19.7 (9.1) 17.7 (9.9)
History of smoking 23 (62%) 29 (62%) 14 (64%) 38 (61%)
History of hypertension 11 (30%) 7 (15%) 6 (27%) 12 (19%)
History of DM 0 4 (9%) 0 4 (6%)
History of hypercholesterolaemia 8 (22%) 7 (15%) 2 (9%) 13 (21%)
BMI; mean (SD) 25.5 (4.1) 25.1 (3.4) 25.2 (3.6) 25.3 (3.8)
GCS on admission *
 13–15 27 (73%) 39 (83%) 14 (64%) 52 (84%)
 9–12 5 (13.5%) 6 (13%) 4 (18%) 7 (11%)
 3–8 5 (13.5%) 2 (4%) 4 (18%) 3 (5%)
WFNS on admission *
 Grade I 14 (38%) 24 (51%) 8 (36%) 31 (50%)
 Grade II 11 (30%) 14 (30%) 5 (23%) 20 (32%)
 Grade III 2 (5%) 1 (2%) 1 (5%) 2 (3%)
 Grade IV 5 (13.5%) 6 (13%) 4 (18%) 7 (11%)
 Grade V 5 (13.5%) 2 (4%) 4 (18%) 3 (5%)
Location of aneurysm
 Anterior circulation 17 (46%) 31 (66%) 12 (55%) 37 (60%)
 Posterior circulation 20 (54%) 16 (34%) 10 (45%) 25 (40%)
SAH treatment
 Coiling 30 (81%) 36 (77%) 19 (86%) 47 (76%)
 Clipping 6 (19%) 11 (23%) 2 (9%) 15 (24%)
Complications
 Any 23 (62%) 18 (38%) 14 (64%) 27 (44%)
 Hydrocephalus 18 (49%) 13 (28%) 13 (59%)† 18 (29%)
 Delayed Cerebral Ischaemia 7 (19%) 7 (15%) 3 (14%) 11 (18%)
 Rebleed 1 (3%) 1 (2%) 0 2 (3%)
 ICH 5 (13.5%) 10 (21%) 3 (14%) 12 (19%)
 IVH 26 (70%) 30 (64%) 13 (59%) 43 (69%)
 Hypertension after SAH 20 (54%) 29 (62%) 14 (64%)* 22 (35%)

*p<0.05.

†OR 3.3 (95% CI 2.7 to 3.8).

‡OR 2.6 (95% CI 2.2 to 3.0).

BMI, body mass index; GCS, Glasgow Coma Scale; ICH, intraparenchymal haematoma; IVH, intraventricular haematoma; PD, pituitary dysfunction; SAH, subarachnoid haemorrhage. WFNS, World Federation of Neurological Surgeons grading scale for patients with SAH.